Analysis of real-world treatment patterns in a matched rheumatology population that continued innovator infliximab therapy or switched to biosimilar infliximab

Analysis of real-world treatment patterns in a matched rheumatology population that continued innovator infliximab therapy or switched to biosimilar infliximab

Yusuf Yazici,1 Lin Xie,2 Adesuwa Ogbomo,2 Lorie A Ellis,3 Kavitha Goyal,4 Amanda Teeple,5 Ismail Simsek6 1Rheumatology, New York University, School of Medicine, New York, NY, USA; 2Health Economics and Outcomes Research, STATinMED Research, Ann Arbor, MI, USA; 3Real World Value and Evidence, Janssen...

Full description

Bibliographic Details
Main Authors: Yazici Y, Xie L, Ogbomo A, Ellis LA, Goyal K, Teeple A, Simsek I
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:Biologics : Targets & Therapy
Subjects:
rheumatoid arthritis
biosimilar
CT-P13
continuer
treatment patterns
Online Access:https://www.dovepress.com/analysis-of-real-world-treatment-patterns-in-a-matched-rheumatology-po-peer-reviewed-article-BTT

Internet

https://www.dovepress.com/analysis-of-real-world-treatment-patterns-in-a-matched-rheumatology-po-peer-reviewed-article-BTT

Similar Items